Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano‐immunotherapy in Breast Cancer Lung Metastasis
Abstract Nano‐immunotherapy regimens have high potential to improve patient outcomes, as already demonstrated in advanced triple negative breast cancer with nanoparticle albumin‐bound paclitaxel and the immune checkpoint blocker (ICB) atezolizumab. This regimen, however, does not lead to cures with...
Autori principali: | , , , , , , , , , , , , , , , , , , |
---|---|
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
Wiley
2021-02-01
|
Serie: | Advanced Science |
Soggetti: | |
Accesso online: | https://doi.org/10.1002/advs.202001917 |